Additional trials expected to report data include: TRIUMPH-1 TRIUMPH-2 TRIUMPH-3 TRIUMPH-5 TRIUMPH-CVOT These studies will evaluate retatrutide in broader obesity populations, diabetes patients, cardiovascular disease populations, and long-term outcomes
We take a more balanced approach in assessing long-term impacts
When I woke up seven hours later, I found a detailed message from a physicians assistantwho I did not communicate with directlylaying out my new plan. I also found I was charged $866 and had been sent a three-month supply of tirzepatide vials that I had been prescribed, despite neither asking for or needing them
Related Video: What Is the Half-Life of Retatrutide
As a result, healthcare providers will typically recommend committing to one medication for several months before considering any changes
But this medication was intended for type 2 diabetes, not weight loss